Ourania Tatsis's Net Worth
$44.8 Million
Who is Ourania Tatsis?
Ourania Tatsis has an estimated net worth of $44.8 Million. This is based on reported shares across multiple companies, which include VERTEX PHARMACEUTICALS INC / MA, and Verve Therapeutics, Inc..
SEC CIK
Ourania Tatsis's CIK is 0001789815
Past Insider Trading and Trends
2020 was Ourania Tatsis's most active year for acquiring shares with 7 total transactions. Ourania Tatsis's most active month to acquire stocks was the month of January. 2020 was Ourania Tatsis's most active year for disposing of shares, totalling 36 transactions. Ourania Tatsis's most active month to dispose stocks was the month of January. 2019 saw Ourania Tatsis paying a total of $443,841.21 for 2,853 shares, this is the most they've acquired in one year. In 2023 Ourania Tatsis cashed out on 21,857 shares for a total of $6,868,541.06, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
VERTEX PHARMACEUTICALS INC / MA (VRTX) Snapshot price: $468
EVP, Chief Reg. & Quality Off.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.24% | -2.17K |
$460.00 | -$1,000,500.00 | 49.1K |
Scheduled
|
Jun 3
| ||
Form 4
| -8.23% | -4.60K |
$441.99 | -$2,033,158.50 | 51.27K |
Scheduled
|
May 30 - May 31
| ||
Form 4
| -6.16% | -3.66K |
$431.20 | -$1,579,490.91 | 55.8K |
Scheduled
|
Feb 23 - Feb 26
| ||
Form 4
| -0.60% | -360.00 |
$421.77 | -$151,837.20 | 59.47K |
Scheduled
|
Feb 21
| ||
Form 4
| -12.25% | -8.35K |
$422.44 | -$3,528,216.53 | 59.83K |
Scheduled
|
Feb 16 - Feb 20
| ||
Form 4
| -3.42% | -2.41K |
$422.41 | -$1,019,709.36 | 68.18K |
Scheduled
|
Feb 9 - Feb 12
| ||
Form 4
| +45.14% | 21.96K |
—
|
—
| 70.59K |
Feb 6 - Feb 7
| |||
Form 4
| -4.89% | -2.50K |
$355.00 | -$887,500.00 | 48.64K |
Aug 23
| |||
Form 4
| -10.11% | -5.75K |
$345.79 | -$1,988,292.50 | 51.14K |
Aug 10
| |||
Form 4
| -6.06% | -3.66K |
$288.96 | -$1,058,177.19 | 56.8K |
Scheduled
|
Feb 24 - Feb 27
| ||
Form 4
| -7.61% | -4.98K |
$292.94 | -$1,458,240.88 | 60.47K |
Scheduled
|
Feb 17 - Feb 21
| ||
Form 4
| -0.49% | -320.00 |
$298.52 | -$95,526.51 | 65.44K |
Scheduled
|
Feb 14
| ||
Form 4
| -6.60% | -4.65K |
$297.14 | -$1,380,803.98 | 65.77K |
Scheduled
|
Feb 10 - Feb 13
| ||
Form 4
| +52.77% | 24.32K |
—
|
—
| 70.41K |
Feb 1
| |||
Form 4
| -2.95% | -1.40K |
$298.97 | -$418,556.74 | 46.09K |
Scheduled
|
Aug 9
| ||
Form 4
| -5.64% | -2.83K |
$250.11 | -$708,572.06 | 47.36K |
Scheduled
|
Mar 17
| ||
Form 4
| -5.49% | -2.92K |
$228.20 | -$665,215.48 | 50.19K |
Scheduled
|
Feb 24 - Feb 25
| ||
Form 4
| -8.02% | -4.63K |
$232.34 | -$1,076,434.72 | 53.1K |
Scheduled
|
Feb 17 - Feb 18
| ||
Form 4
| -2.57% | -1.52K |
$237.23 | -$360,595.34 | 57.74K |
Scheduled
|
Feb 10 - Feb 11
| ||
Form 4
| +87.86% | 27.71K |
—
|
—
| 59.26K |
Feb 1
| |||
Form 4
| -3.19% | -1.04K |
$217.57 | -$225,402.52 | 31.43K |
Feb 24
| |||
Form 4
| -5.80% | -2.00K |
$211.75 | -$423,500.00 | 32.47K |
Feb 17
| |||
Form 4
| -3.45% | -1.23K |
$214.16 | -$263,416.80 | 34.47K |
Feb 10
| |||
Form 4
| +180.25% | 22.96K |
—
|
—
| 35.7K |
Feb 3
| |||
Form 4
| -0.93% | -120.00 |
$284.00 | -$34,080.09 | 12.74K |
Scheduled
|
May 15
| ||
Form 4
|
—
|
0
|
$223.38 | -$95,284.91 | 12.74K |
Scheduled
|
May 6
| ||
Form 4
| -15.47% | -2.33K |
$235.86 | -$550,029.00 | 12.74K |
Scheduled
|
Feb 24 - Feb 25
| ||
Form 4
| -11.07% | -1.88K |
$242.94 | -$455,760.23 | 15.07K |
Scheduled
|
Feb 17 - Feb 18
| ||
Form 4
| +133.67% | 9.69K |
$206.74 | -$63,225.06 | 16.95K |
Scheduled
|
Feb 5 - Feb 6
| ||
Form 4
|
—
|
0
|
$207.53 | -$67,000.00 | 7.25K |
Scheduled
|
Jan 8
| ||
Form 4
| -0.07% | -5.00 |
$205.95 | -$1,029.75 | 7.25K |
Scheduled
|
Nov 15
| ||
Form 4
|
—
|
0
|
$180.58 | -$142,707.06 | 7.25K |
Scheduled
|
Nov 13
| ||
Form 4
| -8.02% | -632.00 |
$168.11 | -$106,247.04 | 7.25K |
Scheduled
|
Oct 1 - Oct 2
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verve Therapeutics, Inc. (VERV) Snapshot price: $5.595
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||